Keyword: Meda

mylan

2. Mylan

For some time, Mylan’s corporate image will be linked with its damaging EpiPen pricing controversy. But aside from all of that negative attention is a booming generics engine that generated $9.43 billion in sales last year, according to Evaluate analysts.